Loading...
Docoh

E-Qure (EQUR)

Document and Entity Information

Document and Entity Information - shares3 Months Ended
Mar. 31, 2021Jul. 06, 2021
Cover [Abstract]
Entity Registrant NameE-Qure Corp.
Entity Central Index Key0001563536
Document Type10-Q
Document Period End DateMar. 31,
2021
Amendment Flagfalse
Current Fiscal Year End Date--12-31
Entity Current Reporting StatusYes
Entity Interactive Data CurrentNo
Entity Filer CategoryNon-accelerated Filer
Entity Small Business Flagtrue
Entity Emerging Growth Companyfalse
Entity Shell Companyfalse
Entity Common Stock, Shares Outstanding34,546,060
Document Fiscal Period FocusQ1
Document Fiscal Year Focus2021

Balance Sheets (Unaudited)

Balance Sheets (Unaudited) - USD ($)Mar. 31, 2021Dec. 31, 2020
Current assets:
Cash $ 19,428 $ 81,070
Total current assets19,428 81,070
Other assets
Total Assets19,428 81,070
Current liabilities:
Accounts payable2,996 2,996
Accrued interest, related party1,564 1,564
Accrued salary, related party337,536 309,456
Loan from shareholder, related party100,000 100,000
Loan from shareholder, unrelated party65,905 65,905
Total current liabilities508,001 479,921
Total liabilities508,001 479,921
Stockholders' equity (deficit):
Preferred stock, $0.00001 par value; 25,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.00001 par value; 500,000,000 shares authorized; and 34,546,060 issued and outstanding at March 31, 2021 and December 31, 2020, respectively.345 345
Additional paid in capital33,809,616 33,805,525
Stock payables615,939 494,891
Accumulated other comprehensive income (loss)(15,790)(17,919)
Accumulated deficit(34,898,683)(34,681,693)
Total stockholders' equity (deficit)(488,573)(398,851)
Total Liabilities and Stockholders' Equity (Deficit) $ 19,428 $ 81,070

Balance Sheets (Unaudited) (Par

Balance Sheets (Unaudited) (Parenthetical) - $ / sharesMar. 31, 2021Dec. 31, 2020
Statement of Financial Position [Abstract]
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized25,000,000 25,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares authorized500,000,000 500,000,000
Common stock, shares issued34,546,060 34,546,060
Common stock, shares outstanding34,546,060 34,546,060

Statements of Operations and Co

Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020
Income Statement [Abstract]
Revenues
Expenses:
General and administrative105,790 93,371
Research and development104,567 59,380
Total210,357 152,751
Other income (expenses):
Foreign currency transaction gain (loss)(2,542)
Interest expense(4,091)(4,136)
Total expenses(6,633)(4,136)
Loss from continuing operations before income taxes(216,990)(156,887)
Income tax
Net loss(216,990)(156,887)
Other comprehensive income (loss)
Foreign currency translation adjustments2,129 214,861
Comprehensive income (loss) $ (214,861)
Basic and diluted net loss per share $ (0.01) $ 0
Weighted average number of common shares outstanding (basic and diluted)34,546,060 34,546,060

Statements of Changes in Stockh

Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)Common Stock [Member]Additional Paid-in Capital [Member]Stock Payable [Member]Accumulated Deficit [Member]Total Stockholders' Comprehensive Income (Loss) [Member]Total
Balance at Dec. 31, 2019 $ 345 $ 33,788,889 $ 21,000 $ (33,069,337) $ (259,103)
Balance, shares at Dec. 31, 201934,546,060
Stock payable 270,976 270,976
Imputed interest 4,136 4,136
Foreign currency adjustment214,861
Net loss (156,887) (156,887)
Balance at Mar. 31, 2020 $ 345 33,793,025 291,976 (34,226,224) (140,878)
Balance, shares at Mar. 31, 202034,546,060
Balance at Dec. 31, 2020 $ 345 33,805,525 494,891 (34,681,693)(17,919)(398,851)
Balance, shares at Dec. 31, 202034,546,060
Imputed interest 4,091 4,091
Foreign currency adjustment 2,129 2,129
Stock payable, related party 121,048 121,048
Net loss (216,990) (216,990)
Balance at Mar. 31, 2021 $ 345 $ 33,809,616 $ 615,939 $ (34,898,683) $ (15,790) $ (488,573)
Balance, shares at Mar. 31, 202134,546,060

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020
Cash flows from operating activities:
Net loss $ (216,990) $ (156,887)
Adjustments required to reconcile net loss to cash used in operating activities:
Imputed interest4,091 4,136
Changes in assets and liabilities:
Increase (decrease) in accounts payable and accrued expenses28,080 57,375
Cash used in operating activities(184,819)(95,376)
Cash flow from financing activities:
Proceeds from stock payable - related party121,048 270,976
Cash provided by financing activities121,048 270,976
Foreign currency translation adjustments on cash and cash equivalents2,129
Change in cash(61,642)175,600
Cash - beginning of period81,070 18,278
Cash - end of period19,428 193,878
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income tax

The Company and Significant Acc

The Company and Significant Accounting Policies3 Months Ended
Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
The Company and Significant Accounting Policies1. The Company and Significant Accounting Policies Organizational Background E-Qure Corp. (“EQURE” or the “Company”)
is a Delaware corporation with offices in Israel. EQURE owns IP of innovate technology of wound healing device (BST). Basis of Presentation: The accompanying financial statements have been prepared
in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company
as a going concern. The Company has not established any source of revenue to cover its operating costs, and as such, has incurred an operating
loss since inception. Significant Accounting Policies Use of Estimates The preparation of financial statements in conformity
with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of
revenues and expenses during the reporting period. Actual results could differ from the estimates. Cash and Cash Equivalent For financial statement presentation purposes, the
Company considers those short-term, highly liquid investments with original maturities of three months or less to be cash or cash equivalents.
There were no cash equivalents as of March 31, 2021 and December 31, 2020. Property and Equipment New property and equipment are recorded at cost. Property
and equipment included in the bankruptcy proceedings and transferred to the Trustee had been valued at liquidation value. Depreciation
is computed using the straight-line method over the estimated useful lives of the assets, generally 5 years. Expenditures for renewals
and betterments are capitalized. Expenditures for minor items, repairs and maintenance are charged to operations as incurred. Gain or
loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place. Valuation of Long-Lived Assets We review the recoverability of our long-lived assets
including equipment, goodwill and other intangible assets, when events or changes in circumstances occur that indicate that the carrying
value of the asset may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value
of the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations. If these
cash flows are less than the carrying value of such asset, an impairment loss is recognized for the difference between estimated fair
value and carrying value. Our primary measure of fair value is based on discounted cash flows. The measurement of impairment requires
management to make estimates of these cash flows related to long-lived assets, as well as other fair value determinations. Stock Based Compensation Stock-based awards are accounted for using the fair
value method in accordance with ASC 718, Share-Based Payments Accounting For Obligations And Instruments Potentially
To Be Settled In The Company’s Own Stock We account for obligations and instruments potentially
to be settled in the Company’s stock in accordance with FASB ASC 815, Accounting for Derivative Financial Instruments. Fair Value of Financial Instruments FASB ASC 825, “Financial Instruments,”
requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the
balance sheet, for which it is practicable to estimate fair value. FASB ASC 825 defines fair value of a financial instrument as the amount
at which the instrument could be exchanged in a current transaction between willing parties. At March 31, 2021 and December 31, 2020,
the carrying value of certain financial instruments (cash and cash equivalents, accounts payable and accrued expenses.) approximates fair
value due to the short-term nature of the instruments or interest rates, which are comparable with current rates. Fair Value Measurements The Company measures fair value under a framework
that utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives
the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the
lowest priority to unobservable inputs (level 3 measurements). The three levels of inputs which prioritize the inputs used in measuring
fair value are: Level 1: Quoted prices (unadjusted) in active markets
that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1
inputs. Level 2: Other inputs that are observable, directly
or indirectly, such as quoted prices for similar assets and liabilities or market corroborated inputs. Level 3: Unobservable inputs are used when little
or no market data is available, which requires the Company to develop its own assumptions about how market participants would value the
assets or liabilities. The fair value hierarchy gives the lowest priority to Level 3 inputs. In determining fair value, the Company utilizes valuation
techniques in its assessment that maximize the use of observable inputs and minimize the use of unobservable inputs. The following table
presents the Company’s financial assets and liabilities that are carried at fair value, classified according to the three categories
described above: Fair Value Measurements at March 31, 2021
Quoted Prices in Active Markets for Identical Assets
Significant Other Observable Inputs
Significant Unobservable Inputs
Total (Level 1) (Level 2) (Level 3)
None $ - $ - $ - $ -
Total assets and liabilities at fair value $ - $ - $ - $ - Fair Value Measurements at December 31, 2020
Quoted Prices in Active Markets for Identical Assets
Significant Other Observable Inputs
Significant Unobservable Inputs
Total (Level 1) (Level 2) (Level 3)
None $ - $ - $ - $ -
Total assets and liabilities at fair value $ - $ - $ - $ - When the Company changes its valuation inputs for
measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it may
need to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these
transfers at the end of the reporting period that the transfers occur. For the fiscal periods ended March 31, 2021 and December 31, 2020,
there were no significant transfers of financial assets or financial liabilities between the hierarchy levels. Earnings per Common Share We compute net income (loss) per share in accordance
with ASC 260, Earning per Share Income Taxes We have adopted ASC 740, Accounting for Income Taxes.
Pursuant to ASC 740, we are required to compute tax asset benefits for net operating losses carried forward. The potential benefits of
net operating losses have not been recognized in these financial statements because the Company cannot be assured it is more likely than
not it will utilize the net operating losses carried forward in future years. We must make certain estimates and judgments in determining
income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of certain tax assets and
liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes. Deferred tax assets and liabilities are determined
based on the differences between financial reporting and the tax basis of assets and liabilities using the tax rates and laws in effect
when the differences are expected to reverse. ASC 740 provides for the recognition of deferred tax assets if realization of such assets
is more likely than not to occur. Realization of our net deferred tax assets is dependent upon our generating sufficient taxable income
in future years in appropriate tax jurisdictions to realize benefit from the reversal of temporary differences and from net operating
loss, or NOL, carryforwards. We have determined it more likely than not that these timing differences will not materialize and have provided
a valuation allowance against substantially all of our net deferred tax asset. Management will continue to evaluate the realizability
of the deferred tax asset and its related valuation allowance. If our assessment of the deferred tax assets or the corresponding valuation
allowance were to change, we would record the related adjustment to income during the period in which we make the determination. Our tax
rate may also vary based on our results and the mix of income or loss in domestic and foreign tax jurisdictions in which we operate. In addition, the calculation of our tax liabilities
involves dealing with uncertainties in the application of complex tax regulations. We recognize liabilities for anticipated tax audit
issues in the U.S. and other tax jurisdictions based on our estimate of whether, and to the extent to which, additional taxes will be
due. If we ultimately determine that payment of these amounts is unnecessary, we will reverse the liability and recognize a tax benefit
during the period in which we determine that the liability is no longer necessary. We will record an additional charge in our provision
for taxes in the period in which we determine that the recorded tax liability is less than we expect the ultimate assessment to be. ASC 740 which requires recognition of estimated income
taxes payable or refundable on income tax returns for the current year and for the estimated future tax effect attributable to temporary
differences and carry-forwards. Measurement of deferred income tax is based on enacted tax laws including tax rates, with the measurement
of deferred income tax assets being reduced by available tax benefits not expected to be realized. Uncertain Tax Positions The Financial Accounting Standards Board issued Interpretation
No. 48, “Accounting for Uncertainty in Income Taxes – an interpretation of FASB Statement No. 109, Accounting for Income Taxes”
(“FIN No. 48”) which was effective for the Company on January 1, 2007. FIN No. 48 addresses the determination of whether tax
benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under FIN No. 48, the Company
may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained
on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements
from such position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized
upon ultimate settlement. FIN No. 48 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
periods and disclosure requirements. We are not under examination by any jurisdiction for
any tax year. At March 31, 2021, we had no material unrecognized tax benefits and no adjustments to liabilities or operations were required
under FIN 48. Recent Accounting Pronouncements In July 2018, the FASB issued ASU No. 2018-10, Codification
Improvements to Topic 842, Leases. The amendments in ASU 2018-10 provide additional clarification and implementation guidance on certain
aspects of the previously issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”) and have the same effective and transition
requirements as ASU 2016-02. Upon the effective date, ASU 2018-10 will supersede the current lease guidance in ASC Topic 840, Leases.
Under the new guidance, lessees will be required to recognize for all leases, lease with the exception of short-term leases, a lease liability,
which is a lessee’s obligation to make payments arising from a lease, measured on a discounted basis. Concurrently, lessees will
be required to recognize a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of,
a specified asset for the lease term. ASU 2018-10 is effective for private companies and emerging growth public companies for interim
and annual reporting periods beginning after December 15, 2019, with early adoption permitted. The guidance is required to be applied
using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative
periods presented in the financial statements. During the year ended December 31, 2020, the Company assessed the impact this guidance
had on its financial statements and concluded that at present ASU No. 2018-10 has no impact on its financial statements due to not having
any commitment to stay in our property longer than a year. Management does not anticipate that the adoption
of these standards will have a material impact on the financial statements.

Stockholders' Equity

Stockholders' Equity3 Months Ended
Mar. 31, 2021
Equity [Abstract]
Stockholders' Equity2. Stockholders’ Equity Common Stock We are currently authorized to issue up to 500,000,000
shares of $0.00001 par value common stock. All issued shares of common stock are entitled to vote on a 1 share/1 vote basis. Issuances of Common Stock During the Period ended
March 31, 2021: During the three-month period ended March 31, 2021,
the Company received proceeds of $121,048 from a related party from 1,210,480 shares of common stock to be issued at $0.10 per share. Issuances of Common Stock During the Period ended
March 31, 2020: The Company did not issue any Common Stock during
the three months ended March 31, 2021. Preferred Stock We are currently authorized to issue up to 25,000,000
shares of $0.00001 par value preferred stock. There are no preferred shares outstanding as of March 31, 2021 and December 31, 2020. Stock Options On January 1, 2015, the Company authorized the adoption
of the 2015 Employee Incentive Plan. Warrants Granted During the year ended December 31, 2018, the Company’s
chief executive officers and chairman converted debt and accrued wages in the aggregate amount of $275,303 into Units consisting of a
total of: (i) 2,753,030 restricted shares, 1,376,515 Class A Warrants exercisable to purchase 0.5 shares of common stock at $0.50 per
shares for a period of 24 months and Class B Warrants exercisable to purchase 0.5 shares of common stock at $1.25 per shares for a period
of 36 months, having the same terms as the Class A and Class B Warrants set forth in the Reg S Unit Offering, and 2,750,000 Class C Warrants
exercisable to purchase one share of Common Stock at a price of $1.00 per Share. The warrants were valued at $385,552 using the Black-
Scholes valuation model and were recorded for a total as loss on conversion on debt under additional paid in capital of $315,900. Following is a table summarizing warrants outstanding
and exercisable along with exercise price.
Name Description Grant Date of Options/Warrants Number of Options/Warrants
Stock Price on Measurement Date Exercise Price of Options/Warrants Terms of Options/warrants
Warrants Class A Shares for cash 09/05/2018 4,777,734 $ 0.08 $ 0.50 2 years
Warrants Class B Shares for cash 09/05/2018 4,777,734 $ 0.08 $ 0.50 3 years
Warrants Class A Debt conversion 07/01/2018 1,376,515 $ 0.07 $ 0.50 2 years
Warrants Class B Debt conversion 07/01/2018 1,376,515 $ 0.07 $ 1.25 3 years
Warrants Class C Debt conversion 07/01/2018 2,750,000 $ 0.07 $ 1.00 10 years
Total 15,058,498 The following table summarizes stock warrant activities
for the three-months ended March 31, 2021 and 2020:
Warrants Outstanding
Balance as of December 31, 2019 15,058,498
Warrants granted -
Warrants exercised -
Warrants canceled and forfeited -
Balance as of March 31, 2020 15,058,498
Warrants vested and exercisable as of March 31, 2020 15,058,498
Balance as of December 31, 2020 12,427,464
Warrants granted -
Warrants exercised -
Warrants Class A canceled and forfeited -
Balance as of march 31, 2021 12,427,464
Warrants Class B and C vested and exercisable as of March 31, 2021 12,427,464

Notes Payable

Notes Payable3 Months Ended
Mar. 31, 2021
Debt Disclosure [Abstract]
Notes Payable3. Notes Payable During period ended March 31, 2021 and 2020, the Company
received no funds related to the issuance of notes. As of March 31, 2021 and December 31, 2020, the Company had outstanding loans due
to related party of $100,000 and $65,905 due to an unrelated party. During period ended March 31, 2021 and 2020, the Company incurred
imputed interest charges of $4,091 and $4,136, respectively.
March 31, 2021 December 31, 2020
Itsik Ben Yesha, CTO $ 100,000 $ 100,000
Michael Cohan, unrelated party $ 65,905 $ 65,905

Related Party Transactions Not

Related Party Transactions Not Disclosed Elsewhere3 Months Ended
Mar. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions Not Disclosed Elsewhere4. Related Party Transactions not Disclosed Elsewhere During period ended March 31, 2021 and 2020, the Company
received no funds related to the issuance of notes. As of March 31, 2021 and December 31, 2020, the Company had outstanding loans due
to Itsik Ben Yesha, our CTO of $100,000. During the period ended March 31, 2021 and 2020, the Company incurred imputed interest charges
of $2,466 and $2,466, respectively, related to the loans outstanding to Itsik Ben Yesha. As of March 31, 2021 and December 31, 2020, the
Company owed $100,000 in notes payable to Itsik Ben Yesha, the CTO and a related party. During the three-month period ended March 31,
2021, the Company received proceeds of $121,048 from a related party from 1,210,480 shares of common stock to be issued at $0.10 per share. As of March 31, 2021 and December 31, 2020, we had
accrued salaries of $337,536 and $309,456, respectively, due to three of our officers. As of March 31, 2021 and December 31, 2020, we had
accrued interest of $1,564, due to Mr. Weissberg, who is the Company’s Chairman of the audit committee. The principal underlying
the note was converted in 2014.

Foreign Currency Translation

Foreign Currency Translation3 Months Ended
Mar. 31, 2021
Foreign Currency [Abstract]
Foreign Currency Translation5. Foreign currency translation The Company maintains its books and record in its
local currency, Israeli Shekel ILS (“ILS”), which is a functional currency as being the primary currency of the economic environment
in which its operation is conducted. Transactions denominated in currencies other than the functional currency are translated into the
functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies
other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet
dates. The resulting exchange differences are recorded in the statements of operations. The reporting currency of the Company is the United
States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In accordance with ASC Topic
830-30, “Translation of Financial Statement”, assets and liabilities of the Company whose functional currency is not US$ are
translated into US$, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing
during the period. The gains and losses resulting from translation of financial statements are recorded as a separate component of accumulated
other comprehensive income (loss) within the statements of changes stockholders’ equity (deficit). Translation of amounts from the local currency of
the Company into US$1 has been made at the following exchange rates:
March 31, 2021 December 31, 2020
Current ISL: US$1 exchange rate 3.33 3.22
Average ISL: US$1 exchange rate 3.27 3.44

Going Concern

Going Concern3 Months Ended
Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern6. Going Concern The accompanying financial statements have been prepared
in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company
as a going concern. The Company has not established any source of revenue to cover its operating costs, and as such, has incurred an operating
loss since inception. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern.
The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and
classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to
continue as a going concern. Our future financing transactions may include the issuance of equity and/or debt securities. We may raise
funds through additional private placements of equity or convertible debt. We do not have any arrangements with potential investors or
lenders to provide us with any additional financing and there can be no assurance that any such additional financing will be available
when required in order to proceed with the business plan.

Subsequent Events

Subsequent Events3 Months Ended
Mar. 31, 2021
Subsequent Events [Abstract]
Subsequent Events7. Subsequent Events There were no subsequent events following the period
ended March 31, 2021 through the date the financial statements were issued that would materially affect the financial statements.

The Company and Significant A_2

The Company and Significant Accounting Policies (Policies)3 Months Ended
Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Use of EstimatesUse of Estimates The preparation of financial statements in conformity
with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of
revenues and expenses during the reporting period. Actual results could differ from the estimates.
Cash and Cash EquivalentsCash and Cash Equivalent For financial statement presentation purposes, the
Company considers those short-term, highly liquid investments with original maturities of three months or less to be cash or cash equivalents.
There were no cash equivalents as of March 31, 2021 and December 31, 2020.
Property and EquipmentProperty and Equipment New property and equipment are recorded at cost. Property
and equipment included in the bankruptcy proceedings and transferred to the Trustee had been valued at liquidation value. Depreciation
is computed using the straight-line method over the estimated useful lives of the assets, generally 5 years. Expenditures for renewals
and betterments are capitalized. Expenditures for minor items, repairs and maintenance are charged to operations as incurred. Gain or
loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.
Valuation of Long-Lived AssetsValuation of Long-Lived Assets We review the recoverability of our long-lived assets
including equipment, goodwill and other intangible assets, when events or changes in circumstances occur that indicate that the carrying
value of the asset may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value
of the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations. If these
cash flows are less than the carrying value of such asset, an impairment loss is recognized for the difference between estimated fair
value and carrying value. Our primary measure of fair value is based on discounted cash flows. The measurement of impairment requires
management to make estimates of these cash flows related to long-lived assets, as well as other fair value determinations.
Stock Based CompensationStock Based Compensation Stock-based awards are accounted for using the fair
value method in accordance with ASC 718, Share-Based Payments
Accounting for Obligations and Instruments Potentially to be Settled in the Company's Own StockAccounting For Obligations And Instruments Potentially
To Be Settled In The Company’s Own Stock We account for obligations and instruments potentially
to be settled in the Company’s stock in accordance with FASB ASC 815, Accounting for Derivative Financial Instruments.
Fair Value of Financial InstrumentsFair Value of Financial Instruments FASB ASC 825, “Financial Instruments,”
requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the
balance sheet, for which it is practicable to estimate fair value. FASB ASC 825 defines fair value of a financial instrument as the amount
at which the instrument could be exchanged in a current transaction between willing parties. At March 31, 2021 and December 31, 2020,
the carrying value of certain financial instruments (cash and cash equivalents, accounts payable and accrued expenses.) approximates fair
value due to the short-term nature of the instruments or interest rates, which are comparable with current rates.
Fair Value MeasurementsFair Value Measurements The Company measures fair value under a framework
that utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives
the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the
lowest priority to unobservable inputs (level 3 measurements). The three levels of inputs which prioritize the inputs used in measuring
fair value are: Level 1: Quoted prices (unadjusted) in active markets
that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1
inputs. Level 2: Other inputs that are observable, directly
or indirectly, such as quoted prices for similar assets and liabilities or market corroborated inputs. Level 3: Unobservable inputs are used when little
or no market data is available, which requires the Company to develop its own assumptions about how market participants would value the
assets or liabilities. The fair value hierarchy gives the lowest priority to Level 3 inputs. In determining fair value, the Company utilizes valuation
techniques in its assessment that maximize the use of observable inputs and minimize the use of unobservable inputs. The following table
presents the Company’s financial assets and liabilities that are carried at fair value, classified according to the three categories
described above: Fair Value Measurements at March 31, 2021
Quoted Prices in Active Markets for Identical Assets
Significant Other Observable Inputs
Significant Unobservable Inputs
Total (Level 1) (Level 2) (Level 3)
None $ - $ - $ - $ -
Total assets and liabilities at fair value $ - $ - $ - $ - Fair Value Measurements at December 31, 2020
Quoted Prices in Active Markets for Identical Assets
Significant Other Observable Inputs
Significant Unobservable Inputs
Total (Level 1) (Level 2) (Level 3)
None $ - $ - $ - $ -
Total assets and liabilities at fair value $ - $ - $ - $ - When the Company changes its valuation inputs for
measuring financial assets and liabilities at fair value, either due to changes in current market conditions or other factors, it may
need to transfer those assets or liabilities to another level in the hierarchy based on the new inputs used. The Company recognizes these
transfers at the end of the reporting period that the transfers occur. For the fiscal periods ended March 31, 2021 and December 31, 2020,
there were no significant transfers of financial assets or financial liabilities between the hierarchy levels.
Earnings Per Common ShareEarnings per Common Share We compute net income (loss) per share in accordance
with ASC 260, Earning per Share
Income TaxesIncome Taxes We have adopted ASC 740, Accounting for Income Taxes.
Pursuant to ASC 740, we are required to compute tax asset benefits for net operating losses carried forward. The potential benefits of
net operating losses have not been recognized in these financial statements because the Company cannot be assured it is more likely than
not it will utilize the net operating losses carried forward in future years. We must make certain estimates and judgments in determining
income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of certain tax assets and
liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes. Deferred tax assets and liabilities are determined
based on the differences between financial reporting and the tax basis of assets and liabilities using the tax rates and laws in effect
when the differences are expected to reverse. ASC 740 provides for the recognition of deferred tax assets if realization of such assets
is more likely than not to occur. Realization of our net deferred tax assets is dependent upon our generating sufficient taxable income
in future years in appropriate tax jurisdictions to realize benefit from the reversal of temporary differences and from net operating
loss, or NOL, carryforwards. We have determined it more likely than not that these timing differences will not materialize and have provided
a valuation allowance against substantially all of our net deferred tax asset. Management will continue to evaluate the realizability
of the deferred tax asset and its related valuation allowance. If our assessment of the deferred tax assets or the corresponding valuation
allowance were to change, we would record the related adjustment to income during the period in which we make the determination. Our tax
rate may also vary based on our results and the mix of income or loss in domestic and foreign tax jurisdictions in which we operate. In addition, the calculation of our tax liabilities
involves dealing with uncertainties in the application of complex tax regulations. We recognize liabilities for anticipated tax audit
issues in the U.S. and other tax jurisdictions based on our estimate of whether, and to the extent to which, additional taxes will be
due. If we ultimately determine that payment of these amounts is unnecessary, we will reverse the liability and recognize a tax benefit
during the period in which we determine that the liability is no longer necessary. We will record an additional charge in our provision
for taxes in the period in which we determine that the recorded tax liability is less than we expect the ultimate assessment to be. ASC 740 which requires recognition of estimated income
taxes payable or refundable on income tax returns for the current year and for the estimated future tax effect attributable to temporary
differences and carry-forwards. Measurement of deferred income tax is based on enacted tax laws including tax rates, with the measurement
of deferred income tax assets being reduced by available tax benefits not expected to be realized.
Uncertain Tax PositionsUncertain Tax Positions The Financial Accounting Standards Board issued Interpretation
No. 48, “Accounting for Uncertainty in Income Taxes – an interpretation of FASB Statement No. 109, Accounting for Income Taxes”
(“FIN No. 48”) which was effective for the Company on January 1, 2007. FIN No. 48 addresses the determination of whether tax
benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under FIN No. 48, the Company
may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained
on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements
from such position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized
upon ultimate settlement. FIN No. 48 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
periods and disclosure requirements. We are not under examination by any jurisdiction for
any tax year. At March 31, 2021, we had no material unrecognized tax benefits and no adjustments to liabilities or operations were required
under FIN 48.
Recent Accounting PronouncementsRecent Accounting Pronouncements In July 2018, the FASB issued ASU No. 2018-10, Codification
Improvements to Topic 842, Leases. The amendments in ASU 2018-10 provide additional clarification and implementation guidance on certain
aspects of the previously issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”) and have the same effective and transition
requirements as ASU 2016-02. Upon the effective date, ASU 2018-10 will supersede the current lease guidance in ASC Topic 840, Leases.
Under the new guidance, lessees will be required to recognize for all leases, lease with the exception of short-term leases, a lease liability,
which is a lessee’s obligation to make payments arising from a lease, measured on a discounted basis. Concurrently, lessees will
be required to recognize a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of,
a specified asset for the lease term. ASU 2018-10 is effective for private companies and emerging growth public companies for interim
and annual reporting periods beginning after December 15, 2019, with early adoption permitted. The guidance is required to be applied
using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative
periods presented in the financial statements. During the year ended December 31, 2020, the Company assessed the impact this guidance
had on its financial statements and concluded that at present ASU No. 2018-10 has no impact on its financial statements due to not having
any commitment to stay in our property longer than a year. Management does not anticipate that the adoption of
these standards will have a material impact on the financial statements.

The Company and Significant A_3

The Company and Significant Accounting Policies (Tables)3 Months Ended
Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring BasisThe following table presents the Company’s financial
assets and liabilities that are carried at fair value, classified according to the three categories described above: Fair Value Measurements at March 31, 2021
Quoted Prices in Active Markets for Identical Assets
Significant Other Observable Inputs
Significant Unobservable Inputs
Total (Level 1) (Level 2) (Level 3)
None $ - $ - $ - $ -
Total assets and liabilities at fair value $ - $ - $ - $ - Fair Value Measurements at December 31, 2020
Quoted Prices in Active Markets for Identical Assets
Significant Other Observable Inputs
Significant Unobservable Inputs
Total (Level 1) (Level 2) (Level 3)
None $ - $ - $ - $ -
Total assets and liabilities at fair value $ - $ - $ - $ -

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)3 Months Ended
Mar. 31, 2021
Equity [Abstract]
Schedule of Warrants Outstanding and ExercisableFollowing is a table summarizing warrants outstanding
and exercisable along with exercise price.
Name Description Grant Date of Options/Warrants Number of Options/Warrants
Stock Price on Measurement Date Exercise Price of Options/Warrants Terms of Options/warrants
Warrants Class A Shares for cash 09/05/2018 4,777,734 $ 0.08 $ 0.50 2 years
Warrants Class B Shares for cash 09/05/2018 4,777,734 $ 0.08 $ 0.50 3 years
Warrants Class A Debt conversion 07/01/2018 1,376,515 $ 0.07 $ 0.50 2 years
Warrants Class B Debt conversion 07/01/2018 1,376,515 $ 0.07 $ 1.25 3 years
Warrants Class C Debt conversion 07/01/2018 2,750,000 $ 0.07 $ 1.00 10 years
Total 15,058,498
Schedule of Warrant ActivityThe following table summarizes stock warrant activities
for the three-months ended March 31, 2021 and 2020:
Warrants Outstanding
Balance as of December 31, 2019 15,058,498
Warrants granted -
Warrants exercised -
Warrants canceled and forfeited -
Balance as of March 31, 2020 15,058,498
Warrants vested and exercisable as of March 31, 2020 15,058,498
Balance as of December 31, 2020 12,427,464
Warrants granted -
Warrants exercised -
Warrants Class A canceled and forfeited -
Balance as of march 31, 2021 12,427,464
Warrants Class B and C vested and exercisable as of March 31, 2021 12,427,464

Notes Payable (Tables)

Notes Payable (Tables)3 Months Ended
Mar. 31, 2021
Debt Disclosure [Abstract]
Schedule of Notes PayableMarch 31, 2021 December 31, 2020
Itsik Ben Yesha, CTO $ 100,000 $ 100,000
Michael Cohan, unrelated party $ 65,905 $ 65,905

Foreign Currency Translation (T

Foreign Currency Translation (Tables)3 Months Ended
Mar. 31, 2021
Foreign Currency [Abstract]
Schedule of Translation of Amounts from Local CurrencyTranslation of amounts from the local currency of
the Company into US$1 has been made at the following exchange rates:
March 31, 2021 December 31, 2020
Current ISL: US$1 exchange rate 3.33 3.22
Average ISL: US$1 exchange rate 3.27 3.44

The Company and Significant A_4

The Company and Significant Accounting Policies (Details Narrative) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash equivalents
Property plant and equipment estimated useful assets5 years
Stock payables $ 615,939 $ 494,891
Number of stock issuable6,159,390
Warrants Class B and C vested and excercisable12,427,464 15,058,498
Likelihood of unfavorable settlement, descriptionThe tax benefits recognized in the financial statements from such position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement.
Unrecognized tax benefits

The Company and Significant A_5

The Company and Significant Accounting Policies - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)Mar. 31, 2021Dec. 31, 2020
Total assets and liabilities at fair value
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Total assets and liabilities at fair value
Significant Other Observable Inputs (Level 2) [Member]
Total assets and liabilities at fair value
Significant Unobservable Inputs (Level 3) [Member]
Total assets and liabilities at fair value

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)3 Months Ended12 Months Ended
Mar. 31, 2021Mar. 31, 2020Dec. 31, 2018Dec. 31, 2020
Common stock, shares authorized500,000,000 500,000,000
Common stock, par value $ 0.00001 $ 0.00001
Common stock, voting rightsAll issued shares of common stock are entitled to vote on a 1 share/1 vote basis.
Proceeds from stock payable, related party $ 121,048 $ 270,976
Stock issued during period, shares1,210,480
Share issued price per share $ 0.10
Preferred stock, shares authorized25,000,000 25,000,000
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, shares outstanding
Number of warrants exercisable, shares15,058,498 15,058,498
Warrants to purchase common stock, value $ 385,552
Loss on debt settlement $ 315,900
Chief Executive Officers and Chairman [Member]
Conversion of debt and accrued wages, value $ 275,303
Number of restricted stock2,753,030
Chief Executive Officers and Chairman [Member] | Class A Warrants [Member]
Warrants to purchase common stock1,376,515
Number of warrants exercisable, shares0.5
Warrant exercise price $ 0.5
Warrant exercisable term24 months
Chief Executive Officers and Chairman [Member] | Class B Warrants [Member]
Number of warrants exercisable, shares0.5
Warrant exercise price $ 1.25
Warrant exercisable term36 months
Chief Executive Officers and Chairman [Member] | Class C Warrants [Member]
Warrants to purchase common stock2,750,000
Number of warrants exercisable, shares1
Warrant exercise price $ 1

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Warrants Outstanding and Exercisable (Details) - $ / shares3 Months Ended
Mar. 31, 2021Dec. 31, 2020
Number of Options/Warrants15,058,498 15,058,498
Warrants Class A [Member]
Warrants, DescriptionShares for cash
Grant Date of Options/WarrantsSep. 5,
2018
Number of Options/Warrants4,777,734
Stock Price on Measurement Date $ 0.08
Exercise Price of Options/Warrants $ 0.50
Terms of Options/Warrants2 years
Warrants Class B [Member]
Warrants, DescriptionShares for cash
Grant Date of Options/WarrantsSep. 5,
2018
Number of Options/Warrants4,777,734
Stock Price on Measurement Date $ 0.08
Exercise Price of Options/Warrants $ 0.50
Terms of Options/Warrants3 years
Warrants Class A [Member]
Warrants, DescriptionDebt conversion
Grant Date of Options/WarrantsJul. 1,
2018
Number of Options/Warrants1,376,515
Stock Price on Measurement Date $ 0.07
Exercise Price of Options/Warrants $ 0.50
Terms of Options/Warrants2 years
Warrants Class B [Member]
Warrants, DescriptionDebt conversion
Grant Date of Options/WarrantsJul. 1,
2018
Number of Options/Warrants1,376,515
Stock Price on Measurement Date $ 0.07
Exercise Price of Options/Warrants $ 1.25
Terms of Options/Warrants3 years
Warrants Class C [Member]
Warrants, DescriptionDebt conversion
Grant Date of Options/WarrantsJul. 1,
2018
Number of Options/Warrants2,750,000
Stock Price on Measurement Date $ 0.07
Exercise Price of Options/Warrants $ 1
Terms of Options/Warrants10 years

Stockholders' Equity - Schedu_2

Stockholders' Equity - Schedule of Warrant Activity (Details) - shares3 Months Ended
Mar. 31, 2021Mar. 31, 2020
Equity [Abstract]
Warrants Outstanding, Beginning Balance12,427,464 15,058,498
Warrants Outstanding, Warrants granted
Warrants Outstanding, Warrants exercised
Warrants Outstanding, Warrants canceled and forfeited
Warrants Outstanding, Warrants Class A canceled and forfeited
Warrants Outstanding, Ending Balance12,427,464 15,058,498
Warrants Class B and C vested and excercisable Ending Balance12,427,464 15,058,498

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020Dec. 31, 2020
Debt Disclosure [Abstract]
Advances from outstanding loans
Loan from shareholder, related party100,000 $ 100,000
Loan from shareholder, unrelated party65,905 $ 65,905
Imputed interest $ 4,091 $ 4,136

Notes Payable - Schedule of Not

Notes Payable - Schedule of Notes Payable (Details) - USD ($)Mar. 31, 2021Dec. 31, 2020
Related party $ 100,000 $ 100,000
Unrelated party65,905 65,905
Michael Cohan [Member]
Unrelated party65,905 65,905
Itsik BenYesha, CTO [Member]
Related party $ 100,000 $ 100,000

Related Party Transactions No_2

Related Party Transactions Not Disclosed Elsewhere (Details Narrative) - USD ($)3 Months Ended
Mar. 31, 2021Mar. 31, 2020Dec. 31, 2020
Advances from outstanding loans
Loan from shareholder, related party100,000 $ 100,000
Imputed interest4,091 4,136
Proceeds from stock payable, related party $ 121,048 $ 270,976
Stock issued during period, shares1,210,480
Share issued price per share $ 0.10
Officers [Member]
Accrued salaries $ 337,536 309,456
Accrued interest $ 1,564
Itsik Ben Yesha, CTO [Member]
Advances from outstanding loans
Loan from shareholder, related party100,000 100,000
Imputed interest2,466 $ 2,466
Notes payable, outstanding $ 100,000 100,000
Mr. Weissberg [Member]
Accrued interest $ 1,564

Foreign Currency Translation -

Foreign Currency Translation - Schedule of Translation of Amounts from Local Currency (Details)Mar. 31, 2021Dec. 31, 2020
Current ISL: US$1 Exchange Rate [Member]
Foreign currency exchange rate, translation3.333.22
Average ISL: US$1 Exchange Rate [Member]
Foreign currency exchange rate, translation3.273.44